Free Trial
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$71.97 -1.66 (-2.25%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$65.52 -6.46 (-8.97%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$71.62
▼
$73.31
50-Day Range
$66.80
▼
$76.66
52-Week Range
$53.66
▼
$76.89
Volume
13,337 shs
Average Volume
35,293 shs
Market Capitalization
$229.15 million
P/E Ratio
21.55
Dividend Yield
1.75%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products, Inc. develops, manufactures and markets medical devices, with a focus on disposable products used in obstetrics, gynecology and neonatal care. Its offerings include devices and accessories for fetal monitoring, labor and delivery, newborn care and related clinical procedures.

Founded in 1978 and headquartered in Midvale, Utah, the company also serves other areas of healthcare, including surgery and emergency care. Its products reach customers in the United States and international markets through a combination of direct sales and distribution channels.

AI Generated. May Contain Errors.

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

UTMD MarketRank™: 
2.119044494025 of 5 stars

Utah Medical Products scored higher than 42% of companies evaluated by MarketBeat, and ranked 649th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 21.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 21.55, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    5.17% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 7.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.68%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 37.13%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Utah Medical Products this week, compared to 1 article on an average week.
  • MarketBeat Follows

    2 people have added Utah Medical Products to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $66,750.00 in company stock, which represents 0.0292% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,750.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

Utah Medical Products: A $25 Million Buyback Isn't Enough
Comparing Neuronetics (NASDAQ:STIM) and Utah Medical Products (NASDAQ:UTMD)
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Utah Medical Products, Inc. Increases Quarterly Dividend
Utah Medical Products, Inc. Reports Results of Tender Offer
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the beginning of 2026. Since then, UTMD shares have increased by 28.6% and is now trading at $71.97.

Utah Medical Products, Inc. (NASDAQ:UTMD) posted its quarterly earnings data on Thursday, October, 22nd. The medical instruments supplier reported $0.88 earnings per share for the quarter. The medical instruments supplier had revenue of $8.62 million for the quarter. Utah Medical Products had a net margin of 30.48% and a trailing twelve-month return on equity of 8.83%.

Top institutional investors of Utah Medical Products include State Street Corp (2.06%), Cardinal Capital Management (0.93%), Everett Harris & Co. CA (0.65%) and Ritholtz Wealth Management (0.55%).
View institutional ownership trends
.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include CME Group (CME), Enphase Energy (ENPH), Accenture (ACN), Avery Dennison (AVY), Ford Motor (F), FactSet Research Systems (FDS) and Pacific Gas & Electric (PCG).

Company Calendar

Record date for 10/5 Dividend
9/17/2026
Ex-Dividend for 10/5 Dividend
9/17/2026
Dividend Payable
10/05/2026
Last Earnings
10/22/2026
Today
11/15/2026
Record date for 1/5 Dividend
12/17/2026
Ex-Dividend for 1/5 Dividend
12/17/2026
Fiscal Year End
12/31/2026
Dividend Payable
1/05/2027
Next Earnings (Estimated)
1/28/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
152
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.34
Trailing P/E Ratio
21.55
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
30.48%
Pretax Margin
35.68%
Return on Equity
8.83%
Return on Assets
8.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
48.62
Quick Ratio
44.27

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
5.94
Cash Flow
$4.36 per share
Price / Cash Flow
16.50
Book Value
$37.23 per share
Price / Book
1.93

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$228.86 million
Optionable
Not Optionable
Beta
0.38

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners